Quinlan Paul T — SEC Form 4 filings
SEC reporting owner CIK 1333277. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2023-12-15 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 7 filings — 74,505 shares, $6,986,425 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 14,696 shares @ $107.97 ($1,586,779) in Oruka Therapeutics, Inc., filed 2026-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | General Counsel | 7 | — | 13 legs · 64,505 sh · $6,758,625 | 9 |
| CymaBay Therapeutics, Inc. (CBAY) | General Counsel | 5 | — | 2 legs · 10,000 sh · $227,800 | 15 |
Form 4 filings — Quinlan Paul T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 10,000 @ $7.80 · Sale (S): 2,900 @ $92.37 · Sale (S): 3,832 @ $93.32 · Sale (S): 601 @ $94.44 · Sale (S): 2,667 @ $95.31 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,039 @ $95.71 | EDGAR |
| 2026-08-14 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 10,000 @ $7.80 · Option exercise (M): 42,000 @ $12.50 · Sale (S): 3,630 @ $106.05 · Sale (S): 10,434 @ $107.14 · Sale (S): 14,696 @ $107.97 · Sale (S): 10,200 @ $109.11 · +4 more | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 733 @ $69.69 | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 733 @ $41.30 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 162,500 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 41,824 · Disposition to issuer (D): 28,438 · Disposition to issuer (D): 233,176 (derivative) · Disposition to issuer (D): 22,167 (derivative) · Disposition to issuer (D): 107,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) · +1 more | EDGAR |
| 2024-03-15 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 41,824 @ $7.89 · Option exercise (M): 41,824 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 28,438 @ $0 · Grant/award (A): 105,625 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $23.58 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $21.98 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2023-12-15 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1333277 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →